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Abstract 
HTLV1 adult T cell lymphoma occurs tends to
be widely disseminated and aggressive, with
only  brief  responses  to  chemotherapy.  Aside
from cervical adenopathy, involvement of head
and neck structures is uncommon and orbital
involvement rare.
We report a case of nasal cavity HTLV lym-
phoma  with  massive  bilateral  orbital  involve-
ment and proptosis, resulting in complete left
and partial right eye amaurosis. No other sites of
disease were found. Response to chemotherapy
was rapid and complete, with almost complete
restoration of vision and oculo-motor function;
the patient has remained in remission for one
year. An associated problem was striking bilater-
al hypertrophic, hyperkeratotic eyelid and breast
lesions due to mite infestation. 
Case Report
A 48 year old, previously healthy woman noted
bilateral, progressive eyelid swelling in Grenada
which  proved  unresponsive  to  eye  drops  pre-
scribed there. This was associated with loss of
vision in both eyes. At least a year earlier she
had noted cutaneous lesions on her left breasts.
Approximately two months after these problems
developed she presented to the Kings County
Hospital Medical Center.
She was a thin woman with some temporal
wasting. There was bilateral conjunctival edema,
massive  on  the  left,  with  proptosis.  She  was
blind in the left eye, with marked visual loss on
the right. Both upper eyelids were hypertrophied
with extensive hyperkeratotic epidermis lesions.
(Figure  1)  Massive,  confluent  lesions  of  the
same type were noted on her breasts. There was
no adenopathy or organomegaly. 
Complete blood count was normal, with no
abnormal lymphocytes, such as flower or Sezary
cells on the blood smear. Calcium was 10.1, albu-
min 3.9, LDH 280. HTLV1 serology was positive.
Chest  x-ray  and  abdominal-pelvic  computer-
automated tomography revealed no adenopathy.
Gd-enhanced  magnetic  resonance  imaging  of
the head revealed a large mass involving the
upper nasal cavity, ethmoid sinuses, with exten-
sive orbital invasion, greater on the left, with
optic  nerve  encasement  (Figure  2).  The  left
sphenoid  and  bilateral  frontal  sinuses  were
obstructed, and the superior aspect of the right
maxillary  sinus  was  involved.  The  left  orbital
mass  was  6.3¥4.1¥3.3  cm;  the  right  medial
retrobulbar  fat  was  involved.  There  was  no
intracranial  extension  but  bone  erosion  was
suggested. Body computer-automated tomogra-
phy revealed no other disease.
A  biopsy  of  the  left  orbital  mass  by
Ophthalmology demonstrated large, highly pleo-
mophic,  and  hyperchromatic  cells  infiltrate.
Immunohistochemistral studies revealed tumor
cells positive for CD45, CD3, CD45, CD45RO,
and CD20, but negative for CD79a, CD56, CD30,
CD15,  TDT,  ALK1,  Bcl6,  Bcl2,  CD10,  S-100,
AE1/AE3,  synaptophysin,  and  Chromogranin.
(Figure 3A-F). The final diagnosis was peripher-
al T cell lymphoma with aberrant expression of
CD20. Eyelid biopsy was negative for lymphoma,
but revealed large clusters of Norwegian scabies
(Sarcoptes scabiei var. hominis) (Figure 4A-B).
She was started on the EPOCH regimen, con-
sisting of continuous infusions of etoposide 50
mg/m
2,  vincristine  0.4  mg/m
2,  doxorubicin  10
mg/m
2 days  1-4,  cyclophosphamide  750  mg/m
2
day 5, prednisone 60 mg/m
2 days 1-5, and ritux-
imab. Response was rapid and complete after 6
cycles;  her  chemosis  subsided  (Figure  5)  and
vision was restored to both eyes, though a partial
left lateral rectus palsy persisted. The eyelid and
breast cutaneous lesions did not subside with
chemotherapy, but resolved completely with oral
iveremectin therapy. She remains in complete
remission 1 year after initiation of chemothera-
py. Nine months later flow cytometry of an appar-
ently normal peripheral blood specimen revealed
2.4 CD25
+ cells/mm
3. 
Discussion
There is only one previous report of orbital
involvement by HTLV1 lymphoma,
1 in a patient
with  acute  ATLL.  Primary  involvement  of  the
globe by HTLV1 cells has been described, often
associated with local opportunistic infection. A
patient of our own with ATLL leukemia developed
frosted branch retinopathy which was found, on
vitreous biopsy, to be due to leukemic cells and
herpes simplex 2 infection. Our patient’s extraor-
dinarily  destructive  orbital  implants  may  have
arisen from a primary lesion in her nasal cavity.
Her severe complications are in contrast to the
results  of  low  grade  B  lymphomatous  involve-
ment of this region. Waldeyer’s ring and sinus
involvement may occur in disseminated HTLV1
lymphomas, but a syndrome of primary involve-
ment of these regions in 6 patients has been
described.
2 As in our patient, these tumors were
destructive but localized, and 5 of the 6 patients
survived relapse-free for 27-78 months (median
44, mean 49) after chemotherapy. This contrasts
with the early relapses usually observed after the
response of disseminated HTLV1 lymphomas to
chemotherapy. 
The expression of CD20, a B cell marker, by
our patient’s tumor cells is rare in HTLV1 lym-
phoma, though previously reported.
3,4 There is
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Figure 1. Hypertrophied upper eye lids.
Figure 2. Computed tomography depict-
ing encasement of optic nerve by tumor.[Rare Tumors 2010; 2:e59] [page 171]
no  evidence  that  it  occurs  in  other  HTLV1
tumors of the head region. The orbital biopsy
specimen was too small for studies of the viral
genome, or T and B cell clonality. But the follow-
ing  data  support  the  diagnosis  of  an  HTLV1-
related T cell lymphoma: i) All tumor cells were
CD3
+;  ii)  All  were  CD79a  negative;  iii)  Our
patient’s cutaneous mite infestation is specific
to HTLV1 lymphomas; vi) There was a high level
of circulating CD25
+ cells in the remission blood
specimen. The pathogenesis of the syndrome of
localized  and  highly  responsive  HTLV1  lym-
phomatous  involvement  of  head  structures  is
not clear. It may be due to a population of lym-
phoma  cells  whose  ability  to  proliferate  is
restricted to this region. Extirpation of this cell
population may therefore be curative. Our and
others’  data
2 suggests  that  aggressive  HTLV1
lymphomatous involvement of  head structures
other than lymph nodes may be localized, and
completely  and  durably  responsive  to
chemotherapy. It may represent a separate sub-
type of HTLV1 lymphoma, in that it is systemical-
ly smoldering or subclinical, but locally aggres-
sive. Gross cutaneous mite infestation has been
reported  in  other  patients  with  HTLV1  lym-
phomas,
5 though we have not observed it in sev-
eral hundred patients of Caribbean origin with
HTLV1 lymphomas at our institution. HTLV1 lym-
phomas often involve the skin, but do not cause
hyperkeratosis. It is therefore important to biop-
sy such lesions. Opportunistic mite infestation
has not been reported in association with other
lymphomas  or  with  immune  deficiency.  The
basis of HTLV1 patients’ specific susceptibility to
mite  infestation  is  not  known.  Eyelid  edema
caused by obstruction of lymphatic drainage by
orbital  tumors  and  secondary  proptosis  may
have facilitated extensive mite infestation of the
eyelids. But no mites were found in the orbital
biopsy, which suggests that they did not con-
tribute to her proptosis.
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Case Report
Figure 5. Picture of patient's eyelids after
treatment revealing almost complete reso-
lution as compared to initial presentation.
Figure 3. (A) Biopsy showed large, highly pleomorphic, and hyperchromatic cells infil-
trates. Hemotoxylin-Eosin stain @ 200x magnification. Immunohistochemical studies
performed  on  paraffin  sections  at  200x  magnification:  (B)  CD  45  (C)  CD3  (D)
CD45RO (E) CD20 (F) CD79a 
Figure 4. Skin biopsy taken from patient revealing mite infestation.
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